303 related articles for article (PubMed ID: 4271860)
1. The pharmacology of extrapyramidal movement disorders.
Klawans HL
Monogr Neural Sci; 1973; 2():1-136. PubMed ID: 4271860
[No Abstract] [Full Text] [Related]
2. Therapeutics of disordered movement.
Sears ES
Am Fam Physician; 1977 Sep; 16(3):145-54. PubMed ID: 143204
[TBL] [Abstract][Full Text] [Related]
3. [Basis, clinical picture and therapy of diseases of the extrapyramidal-motoric system (EPMS)].
Völler GW; Deze J
Z Allgemeinmed; 1975 Mar; 51(8):353-73. PubMed ID: 1094755
[No Abstract] [Full Text] [Related]
4. [Dystonias].
Saïd G
Nouv Presse Med; 1972 Feb; 1(8):527-32. PubMed ID: 4401063
[No Abstract] [Full Text] [Related]
5. Involuntary movement disorders.
Still CN
Neurol Clin; 1984 Feb; 2(1):71-89. PubMed ID: 6239089
[TBL] [Abstract][Full Text] [Related]
6. [Specific therapy of extrapyramidal-motor syndromes].
Hartmann-von Monakow K
Bibl Psychiatr Neurol; 1969; 139():705-11. PubMed ID: 4257724
[No Abstract] [Full Text] [Related]
7. [Treatment of Parkinson's disease and extrapyramidal syndromes with classical drugs (what can be expected from them in the levodopa era and which should be used)].
Sigwald J
Therapeutique; 1972 Nov; 48(9):561-8. PubMed ID: 4650525
[No Abstract] [Full Text] [Related]
8. The pharmacology of choreatic movement disorders.
Klawans HL; Weiner WJ
Prog Neurobiol; 1976; 6(1):49-80. PubMed ID: 132681
[No Abstract] [Full Text] [Related]
9. [The use of levodopa in diseases other than Parkinsonism].
Barbeau A
Union Med Can; 1972 May; 101(5):849-52. PubMed ID: 4666887
[No Abstract] [Full Text] [Related]
10. Rationale for the use of L-dopa in the torsion dystonias.
Barbeau A
Neurology; 1970 Nov; 20(11):96-102. PubMed ID: 4991253
[No Abstract] [Full Text] [Related]
11. [Experience with using amedin in children with movement disorders of extrapyramidal and labyrinth origin].
Panfilova ZP; Kaganova ED; Skubak VV
Zh Nevropatol Psikhiatr Im S S Korsakova; 1978; 78(10):1495-7. PubMed ID: 716725
[TBL] [Abstract][Full Text] [Related]
12. [Dopamine and the parkinsonism-chorea antagonism].
Bulandra R; Serbanesco A
Rev Neurol (Paris); 1972 Aug; 127(2):315. PubMed ID: 4147105
[No Abstract] [Full Text] [Related]
13. [Neurologic indications for bromocriptine (in addition to Parkinson's disease)].
Destee A
LARC Med; 1984 Feb; 4(2):107-11. PubMed ID: 6232436
[No Abstract] [Full Text] [Related]
14. [Treatment of parkinsonism with the drug L-DOPA].
Stoliarova LG; Kistenev BA
Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(2):199-205. PubMed ID: 4795170
[No Abstract] [Full Text] [Related]
15. Reflex recovery curves in extrapyramidal disorders.
Sax DS; Johnson TL; Cooper IS
Adv Neurol; 1976; 14():285-96. PubMed ID: 133596
[No Abstract] [Full Text] [Related]
16. [Symposium on diseases of the basal ganglia. Physiological and clinical implications of thalamic surgery for dystonia and torticollis. II].
Cooper IS
Rev Bras Med; 1968 Nov; 25(11):774-80. PubMed ID: 4388626
[No Abstract] [Full Text] [Related]
17. [Principles of the pathogenetic therapy of congenital extrapyramidal diseases].
Tkachev RA; Markova ED; Gotovtseva EV; Barkhatova VP; Ivanova-Smolenskaia IA
Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(4):513-9. PubMed ID: 4705405
[No Abstract] [Full Text] [Related]
18. The role of basal ganglia in rhythmic movement.
Freund HJ; Hefter H
Adv Neurol; 1993; 60():88-92. PubMed ID: 8420222
[No Abstract] [Full Text] [Related]
19. Treatment of dyskinetic and dystonic disorders with CF 25-397: clinical and pharmacological aspects.
Frattola L; Albizzati MG; Bassi S; Spano PF; Trabucchi M
Adv Biochem Psychopharmacol; 1980; 23():381-6. PubMed ID: 6446848
[No Abstract] [Full Text] [Related]
20. [Experiences with memantine in the treatment of severe spastic and extrapyramidal movement disorders in combination with stereotaxic surgery].
Mundinger F; Milios E
Nervenarzt; 1985 Feb; 56(2):106-9. PubMed ID: 3885059
[No Abstract] [Full Text] [Related]
[Next] [New Search]
